Trial Profile
Butrans for Treatment of Restless Legs Syndrome
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 27 Oct 2023
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 24 Oct 2023 Planned initiation date changed from 1 Dec 2014 to 1 Apr 2014.
- 06 Jan 2015 Status changed from not yet recruiting to withdrawn prior to enrolment, according to ClinicalTrials.gov record.
- 19 May 2014 New trial record